Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Risk Management and Healthcare Policy
|
November 26, 2015
The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia
Klaus Rose, Philip D Walson
International Journal of Women'S Dermatology
|
April 19, 2019
Pediatric melanoma-The whole (conflicts of interest) story
Klaus Rose, Jane M Grant-Kels
Children (Basel, Switzerland)
|
March 21, 2018
Pediatric Melanoma and Drug Development
Klaus Rose, Jane M Grant-Kels
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2018
Most adolescents' melanomas are conventional malignant adult-type melanomas
Klaus Rose, Jane M Grant-Kels
Therapeutic Innovation & Regulatory Science
|
December 12, 2018
The Meanings of "Pediatric Drug Development"
Klaus Rose, Jane M Grant-Kels
Pharmaceutical Medicine
|
January 16, 2021
The Term "Juvenile Idiopathic Arthritis (JIA)" is Misleading. It Will not be Sufficient to Just Replace this Term
Klaus Rose, Oishi Tanjinatus, Earl B Ettienne
Current Therapeutic Research, Clinical and Experimental
|
August 8, 2019
Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia
Klaus Rose, David Neubauer, Jane M Grant-Kels
Rambam Maimonides Medical Journal
|
July 24, 2019
Rational Use of Medicine in Children-The Conflict of Interests Story. A Review
Klaus Rose, David Neubauer, Jane M Grant-Kels
Expert Opinion on Pharmacotherapy
|
November 11, 2024
Therapeutic orphans, off-label, pediatric drug development: towards reasonable pharmacotherapy for minors
Klaus Rose, Jane M Grant-Kels, Pasquale Striano
Rambam Maimonides Medical Journal
|
September 24, 2019
Too Many Avoidable Suicides Occur Worldwide in Young Patients
Klaus Rose, David Neubauer, Jane M Grant-Kels
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Risk Management and Healthcare Policy
|
November 26, 2015
The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia
Klaus Rose, Philip D Walson
International Journal of Women'S Dermatology
|
April 19, 2019
Pediatric melanoma-The whole (conflicts of interest) story
Klaus Rose, Jane M Grant-Kels
Children (Basel, Switzerland)
|
March 21, 2018
Pediatric Melanoma and Drug Development
Klaus Rose, Jane M Grant-Kels
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2018
Most adolescents' melanomas are conventional malignant adult-type melanomas
Klaus Rose, Jane M Grant-Kels
Therapeutic Innovation & Regulatory Science
|
December 12, 2018
The Meanings of "Pediatric Drug Development"
Klaus Rose, Jane M Grant-Kels
Pharmaceutical Medicine
|
January 16, 2021
The Term "Juvenile Idiopathic Arthritis (JIA)" is Misleading. It Will not be Sufficient to Just Replace this Term
Klaus Rose, Oishi Tanjinatus, Earl B Ettienne
Current Therapeutic Research, Clinical and Experimental
|
August 8, 2019
Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia
Klaus Rose, David Neubauer, Jane M Grant-Kels
Rambam Maimonides Medical Journal
|
July 24, 2019
Rational Use of Medicine in Children-The Conflict of Interests Story. A Review
Klaus Rose, David Neubauer, Jane M Grant-Kels
Expert Opinion on Pharmacotherapy
|
November 11, 2024
Therapeutic orphans, off-label, pediatric drug development: towards reasonable pharmacotherapy for minors
Klaus Rose, Jane M Grant-Kels, Pasquale Striano
Rambam Maimonides Medical Journal
|
September 24, 2019
Too Many Avoidable Suicides Occur Worldwide in Young Patients
Klaus Rose, David Neubauer, Jane M Grant-Kels
Page
of 5